Losartan reduces mortality in a genetic model of heart failure

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 382, Issue 3, 2010, Pages 265-278

  Günther, Sophie ^a   Baba, Hideo A ^b   Hauptmann, Steffen ^a   Holzhausen, Hans Jürgen ^a   Großmann, Claudia ^a   Punkt, Karla ^c   Kusche, Tina ^c   Jones, Larry R ^d   Gergs, Ulrich ^a   Neumann, Joachim ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CSQ mice; Heart failure; Losartan

Indexed keywords

2 BUTYL 4 CHLORO 1 [[2' (1H TETRAZOL 5 YL) 4 BIPHENYLYL]METHYL] 5 IMIDAZOLECARBOXYLIC ACID; ANGIOTENSIN II ANTAGONIST; LOSARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; GENETIC MODEL; HEART FAILURE; HEART FUNCTION; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; MALE; MORTALITY; MOUSE; NONHUMAN; SARCOPLASMIC RETICULUM; TRANSGENIC MOUSE; WILD TYPE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; CALSEQUESTRIN; DISEASE MODELS, ANIMAL; FEMALE; FIBROSIS; HEART FAILURE; HEMODYNAMICS; LOSARTAN; MALE; MICE; MICE, TRANSGENIC; ORGAN SIZE; TIME FACTORS;

EID: 77957580784     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-010-0544-3     Document Type: Article

References (50)

1. N Alpert M Gordon 1962 Myofibrillar adenosine triphosphatase activity in congestive heart failure Am J Physiol 20 940 946
2. HA Baba T Iwai M Bauer M Irlbeck KW Schmid HG Zimmer 1999 Differential effects of angiotensin II receptor blockade on pressure-induced left ventricular hypertrophy and fibrosis in rats J Mol Cell Cardiol 31 445 455 10.1006/jmcc.1998.0879 1:CAS:528:DyaK1MXhs1Wrtbg%3D 10093056 (Pubitemid 29089892)
3. MC Cho A Rapacciuolo WJ Koch Y Kobayashi LR Jones HA Rockman 1999 Defective beta-adrenergic receptor signaling precedes the development of dilated cardiomyopathy in transgenic mice with calsequestrin overexpression J Biol Chem 274 22251 22256 10.1074/jbc.274.32.22251 1:CAS:528:DyaK1MXlt1CgurY%3D 10428792 (Pubitemid 29379257)
4. I Crozier H Ikram N Awan Z Cleland N Stephen K Dickstein M Frey J Young G Klinger L Makris E Ruscinska 1995 Losartan in heart failure. Hemodynamic effects and tolerability. Losartan Hemodynamic Study Group Circulation 91 691 697 1:STN:280:DyaK2M7ivFaitg%3D%3D 7828295
5. A Daul M Elter-Schulz U Poller F Jockenhovel K Pönicke F Boomsma AJ Man in't Veld RF Schäfers OE Brodde 1995 Dose-dependent separation of dopaminergic and adrenergic effects of epinine in healthy volunteers Naunyn-Schmiedeberg's Arch Pharmacol 352 429 437 10.1007/BF00172781 1:CAS:528:DyaK2MXovFWnt7k%3D
6. K Dickstein P Chang R Willenheimer S Haunsø J Remes C Hall J Kiekskus 1995 Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure J Am Coll Cardiol 26 438 445 10.1016/0735-1097(95)80020-H 1:CAS:528:DyaK2MXntlKht7c%3D 7608448
7. M Flesch A Höper L Dell'Italia K Evans R Bond R Peshock A Diwan TA Brinsa CC Wei N Sivasubramanian FG Spinale DL Mann 2003 Activation and functional significance of the renin-angiotensin system in mice with cardiac restricted overexpression of tumor necrosis factor Circulation 108 598 604 10.1161/01.CIR.0000081768.13378.BF 1:CAS:528:DC%2BD3sXlvVWqsbs%3D 12874189 (Pubitemid 36961176)
8. VB Harding LR Jones RL Lefkowitz WJ Koch HA Rockman 2001 Cardiac beta ARK1 inhibition prolongs survival and augments beta blocker therapy in a mouse model of severe heart failure Proc Natl Acad Sci USA 98 5809 5814 10.1073/pnas.091102398 1:CAS:528:DC%2BD3MXjs1Wntrs%3D 11331748 (Pubitemid 32435724)
9. S Huke BC Knollmann 2010 Increased myofilament Ca (2+)-sensitivity and arrhythmia susceptibility J Mol Cell Cardiol 48 824 833 10.1016/j.yjmcc.2010.01. 011 1:CAS:528:DC%2BC3cXksFCrs78%3D 20097204
10. N Ikemoto M Ronjat LG Meszaros M Koshita 1989 Postulated role of calsequestrin in the regulation of calcium release from sarcoplasmic reticulum Biochemistry 28 6764 6771 10.1021/bi00442a033 1:CAS:528:DyaL1MXksleit7o%3D 2790030
11. N Ikemoto B Antoniu JJ Kang LG Meszaros M Ronjat 1991 Intravesicular calcium transient during calcium release from sarcoplasmic reticulum Biochemistry 30 5230 5237 10.1021/bi00235a017 1:CAS:528:DyaK3MXit1eks70%3D 2036390
12. LR Jones L Zhang K Sanborn AO Jorgensen J Kelley 1995 Purification, primary structure, and immunological characterization of the 26-kDa calsequestrin binding protein (junctin) from cardiac junctional sarcoplasmic reticulum J Biol Chem 270 30787 30796 10.1074/jbc.270.51.30787 1:CAS:528:DyaK28XhtFKrsQ%3D%3D 8530521 (Pubitemid 26005148)
13. 2+ signaling in transgenic mouse cardiac myocytes overexpressing calsequestrin J Clin Invest 101 1385 1393 10.1172/JCI1362 1:CAS:528:DyaK1cXitleksL0%3D 9525981
14. U Karlsson RL Schultz 1965 Fixation of the central nervous system for electron microscopy by aldehyde perfusion J Ultrastruct Res 12 160 206 10.1016/S0022-5320(65)80014-4 1:STN:280:DyaF2M%2FpsVSjuw%3D%3D 14289426
15. T Kawasaki M Kasai 1994 Regulation of calcium channel in sarcoplasmic reticulum by calsequestrin Biochem Biophys Res Commun 199 1120 1127 10.1006/bbrc.1994.1347 1:CAS:528:DyaK2cXksFantLo%3D 8147852 (Pubitemid 24174775)
16. U Kirchhefer J Neumann HA Baba F Begrow U Reinke W Schmitz YM Kobayashi LR Jones 2001 Cardiac hypertrophy and impaired relaxation in transgenic mice overexpressing triadin 1 J Biol Chem 276 4142 4149 10.1074/jbc.M006443200 1:CAS:528:DC%2BD3MXht1Gnsrw%3D 11069905
17. U Kirchhefer HA Baba P Boknik KM Breeden N Mavila N Brüchert I Justus M Matus W Schmitz AA Depaoli-Roach J Neumann 2005 Enhanced cardiac function in mice overexpressing protein phosphatase Inhibitor-2 Cardiovasc Res 68 98 108 10.1016/j.cardiores.2005.05.019 1:CAS:528:DC%2BD2MXpvV2rs74%3D 15975567 (Pubitemid 41253560)
18. BC Knollmann BEC Knollmann-Ritschel NJ Weissmann LR Jones M Morad 2000 Remodelling of ionic currents in hypertrophied and failing hearts of transgenic mice overexpressing calsequestrin J Physiol 525 483 498 10.1111/j.1469-7793. 2000.t01-1-00483.x 1:CAS:528:DC%2BD3cXktl2ktrg%3D 10835049
19. YM Kobayashi A Alseikhan LR Jones 2000 Localization and characterization of the calsequestrin-binding domain of triadin 1. Evidence for a charged beta-strand in mediating the protein-protein interaction J Biol Chem 275 17639 17646 10.1074/jbc.M002091200 1:CAS:528:DC%2BD3cXktFakt7o%3D 10748065 (Pubitemid 30430811)
20. JF LeClercq B Swynghedauw P Bouveret C Faucomprez V Piguet 1976 Myofibrillar ATPase, DNA and hydroxyproline content of human hypertrophied heart Eur J Clin Investig 6 27 34 10.1111/j.1365-2362.1976.tb00490.x 1:STN:280:DyaE287jvFOguw%3D%3D
21. DS Lim S Lutucuta P Bachireddy K Youker A Evans M Entman R Roberts AJ Marian 2001 Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy Circulation 103 789 791 1:CAS:528:DC%2BD3MXhs1WhtL0%3D 11171784
22. B Linck P Bokník S Huke U Kirchhefer J Knapp H Lüss FU Müller J Neumann Z Tanriseven U Vahlensieck HA Baba LR Jones KD Philipson W Schmitz 2000 Functional properties of transgenic mouse hearts overexpressing both calsequestrin and the Na(+)-Ca(2+) exchanger J Pharmacol Exp Ther 294 648 657 1:CAS:528:DC%2BD3cXltlKgsbc%3D 10900244
23. KJ Livak TD Schmittgen 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method Methods 25 402 408 10.1006/meth.2001.1262 1:CAS:528:DC%2BD38XhtFelt7s%3D 11846609 (Pubitemid 34164012)
24. MW Lo J Toh SE Emmert MA Ritter CI Furtek H Lu WS Colucci BF Uretsky E Rucinska 1998 Pharmacokinetics of intravenous and oral losartan in patients with heart failure J Clin Pharmacol 38 525 532 1:CAS:528:DyaK1cXktleisrw%3D 9650542
25. OH Lowry NJ Rosebrough AL Farr RJ Randall 1951 Protein measurements with the Folin phenol reagent J Biol Chem 193 265 275 1:CAS:528:DyaG38XhsVyrsw%3D%3D 14907713
26. JJ Milavetz TE Raya CS Johnson E Morkin S Goldman 1996 Survival after myocardial infarction in rats: captopril versus losartan J Am Coll Cardiol 27 714 719 10.1016/0735-1097(95)00506-4 1:CAS:528:DyaK28Xit1Cksr8%3D 8606287 (Pubitemid 26080396)
27. F Nakamura M Nagano R Kobayashi J Higahi H Mikami N Kawaguchi S Onishi T Ogihara 1994 Chronic administration of angiotensin II receptor antagonist, TCV-116, in cardiomyopathic hamsters Am J Physiol 267 H2297 H2304 1:CAS:528:DyaK2MXivFGlu74%3D 7810730
28. M Otsuka H Takahashi M Shiratori H Chiba S Abe 2004 Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist Thorax 59 31 38 10.1136/thx.2003.000893 1:STN:280:DC%2BD3snhtFaqsg%3D%3D 14694243 (Pubitemid 38067969)
29. ED Pagani AA Alousi AM Grant TM Older SW Dziuban Jr PD Allen 1988 Changes in myofibrillar content and Mg-ATPase activity in ventricular tissues from patients with heart failure caused by coronary artery disease, cardiomyopathy, or mitral valve insufficiency Circ Res 63 380 385 1:CAS:528:DyaL1cXlt1Kktr0%3D 2969307
30. G Paizis RE Gilbert ME Cooper P Murthi JM Schembri LL Wu JR Rumble DJ Kelley C Tikellis A Cox RA Smallwood PW Angus 2001 Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis J Hepatol 35 376 385 10.1016/S0168-8278(01)00146-5 1:CAS:528:DC%2BD3MXnslKrsbo%3D 11592599 (Pubitemid 32844192)
31. C Perrino SV Naga Prasad M Patel MJ Wolf HA Rockman 2005 Targeted inhibition of beta-adrenergic receptor kinase-1-associated phosphoinositide-3 kinase activity preserves beta-adrenergic receptor signaling and prolongs survival in heart failure induced by calsequestrin overexpression J Am Coll Cardiol 45 1862 1870 10.1016/j.jacc.2005.02.062 1:CAS:528:DC%2BD2MXpsVCqt7k%3D 15936620 (Pubitemid 40779869)
32. RM Phillips P Narayan AM Gómez K Dilly LR Jones WJ Lederer RA Altschuld 1998 Sarcoplasmic reticulum in heart failure: central player or bystander? Cardiovasc Res 37 346 351 10.1016/S0008-6363(97)00260-5 1:CAS:528:DyaK1cXitVKru7g%3D 9614491 (Pubitemid 28165996)
33. K Punkt I Erzen 2000 Changes of enzyme activities in the myocardium and skeletal muscle fibres of cardiomyopathic hamsters. A cytophotometrical study Exp Toxicol Pathol 52 103 110 1:CAS:528:DC%2BD3cXksFWkurg%3D 10965983
34. K Punkt V Adams A Linke K Welt 1997 The correlation of cytophotometrically and biochemically measured enzyme activities: changes in the myocardium of diabetic and hypoxic diabetic rats, with and without Ginkgo biloba extract treatment Acta Histochem 99 291 299 1:CAS:528:DyaK2sXmtFSit70%3D 9381912
35. G Qing R Garcia 1992 Chronic captopril and losartan (DuP 753) administration in rats with high-output heart failure Am J Physiol 263 H833 H840 1:CAS:528:DyaK38XmtVCqs70%3D 1415610
36. HA Rockman RS Ross AN Harris KU Knowlton ME Steinhelper LJ Field J Ross Jr KR Chien 1991 Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy Proc Natl Acad Sci USA 88 8277 8281 10.1073/pnas.88.18.8277 1:CAS:528:DyaK3MXmslais7k%3D 1832775
37. Y Sato DG Ferguson H Sako GW Dorn II VJ Kadambi A Yatani BD Hoit RA Walsh EG Kranias 1998 Cardiac-specific overexpression of mouse cardiac calsequestrin is associated with depressed cardiovascular function and hypertrophy in transgenic mice J Biol Chem 273 28470 28477 10.1074/jbc.273.43.28470 1:CAS:528:DyaK1cXntVClsbg%3D 9774476 (Pubitemid 28496153)
38. Y Sato H Kiriazis A Yatani AG Schmidt H Hahn DG Ferguson H Sako S Mitarai R Honda L Mesnard-Roiller KF Frank B Beyermann G Wu K Fujimori GW Dorn II EG Kranias 2001 Rescue of contractile parameters and myocyte hypertrophy in calsequestrin overexpressing myocardium by phospholamban ablation J Biol Chem 276 9392 9399 10.1074/jbc.M006889200 1:CAS:528:DC%2BD3MXisVCmsLs%3D 11115498
39. H Schunkert J Sadoshima T Cornelius Y Kagaya EO Weinberg S Izumo G Riegger BH Lorell 1995 Angiotensin II-induced growth responses in isolated adult rat hearts. Evidence for load-independent induction of cardiac protein synthesis by angiotensin II Circ Res 76 489 497 1:CAS:528:DyaK2MXkt1Wrsr0%3D 7859394
40. BT Scott HK Simmerman JH Collins B Nadal-Ginard LR Jones 1988 Complete amino acid sequence of canine cardiac calsequestrin deduced by cDNA cloning J Biol Chem 263 8958 8964 1:CAS:528:DyaL1MXhvFWquw%3D%3D 3379055
41. Q Shao B Ren HK Saini T Netticadan N Takeda NS Dhalla 2005 Sarcoplasmic reticulum Ca2+ transport and gene expression in congestive heart failure are modified by imidapril treatment Am J Physiol Heart Circ Physiol 288 H1674 H1682 10.1152/ajpheart.00945.2004 1:CAS:528:DC%2BD2MXjtlOrtL4%3D 15576437 (Pubitemid 40417991)
42. T Sladek J Sladkova F Kolar F Papousek N Cicutti B Korecky K Rakusan 1996 The effect of AT1 receptor antagonist on chronic cardiac response to coronary artery ligation in rats Cardiovasc Res 31 568 576 1:CAS:528:DyaK28XjsVersro%3D 8689648
43. JF Smits C van Krimpen RG Schoemaker JP Cleutjens MJ Daemen 1992 Angiotensin II receptor blockade after myocardial infarction in rats: effects on hemodynamics, myocardial DNA synthesis, and interstitial collagen content J Cardiovasc Pharmacol 20 772 778 1:CAS:528:DyaK3sXhs1SntA%3D%3D 1280740
44. YJ Suzuki T Ikeda SS Shi K Kitta YM Kobayashi M Morad LR Jones JB Blumberg 1999 Regulation of GATA-4 and AP-1 in transgenic mice overexpressing cardiac calsequestrin Cell Calcium 25 401 407 10.1054/ceca.1999.0037 1:CAS:528:DyaK1MXms1OgtLw%3D 10579051 (Pubitemid 29481466)
45. The SOLVD Investigators 1992 Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions N Engl J Med 327 685 691 10.1056/ NEJM199209033271003
46. GF Tomaselli DJ Beuckelmann HG Calkins RD Berger PD Kessler JH Lawrence D Kass AM Feldman E Marban 1994 Sudden cardiac death in heart failure. The role of abnormal repolarization Circ Res 90 2534 2539 1:STN:280: DyaK2M%2Fktlaisg%3D%3D
47. Writing Group to Review New Evidence and Update the 2005 Guideline for the Management of Patients with Chronic Heart Failure Writing on Behalf of the 2005 Heart Failure Writing Committee 2009 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 119 1977 2016 10.1161/ CIRCULATIONAHA.109.192064
48. A Yang D Sonin L Jones WH Barry BT Liang 2004 A beneficial role of cardiac P2X4 receptors in heart failure: rescue of the calsequestrin overexpression model of cardiomyopathy Am J Physiol Heart Circ Physiol 287 H1096 H1103 10.1152/ajpheart.00079.2004 1:CAS:528:DC%2BD2cXnvVaqs7o%3D 15130891 (Pubitemid 39096654)
49. L Zhang J Kelley G Schmeiser YM Kobayashi LR Jones 1997 Complex formation between junctin, triadin, calsequestrin, and the ryanodine receptor. Proteins of the cardiac junctional sarcoplasmic reticulum membrane J Biol Chem 272 23389 23397 10.1074/jbc.272.37.23389 1:CAS:528:DyaK2sXmt1WisLs%3D 9287354 (Pubitemid 27392481)
50. B Zhu Y Sun RE Sievers AE Browne S Pulukurthy K Sudhir RJ Lee TM Chou K Chatterjee WW Parmley 2000 Comparative effects of pretreatment with captopril and losartan on cardiovascular protection in a rat model of ischemia-reperfusion J Am Coll Cardiol 35 787 795 10.1016/S0735-1097(99)00592-6 1:CAS:528: DC%2BD3cXitVCjtr4%3D 10716484 (Pubitemid 30170254)